Literature DB >> 1406625

Identification of a 60-kilodalton Rb-binding protein, RBP60, that allows the Rb-E2F complex to bind DNA.

S K Ray1, M Arroyo, S Bagchi, P Raychaudhuri.   

Abstract

Several reports have indicated that the product of the retinoblastoma gene (Rb) complexes with the transcription factor E2F. We present evidence that the DNA-binding of the Rb-E2F complex involves another cellular factor. Addition of Rb to purified preparations of E2F does not generate an Rb-E2F complex that can bind DNA, and in fact, we see an inhibition of the DNA-binding ability of E2F. On the other hand, addition of Rb to cruder preparations of E2F results in the formation of an Rb-E2F complex (E2Fr) that can bind DNA and produces a distinct complex in gel retardation assays. We have identified and purified a 60-kDa protein that allows the Rb-E2F complex to bind DNA, and we show that this 60-kDa protein exerts its effect by directly interacting with Rb.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1406625      PMCID: PMC360356          DOI: 10.1128/mcb.12.10.4327-4333.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.

Authors:  S W Hiebert; S P Chellappan; J M Horowitz; J R Nevins
Journal:  Genes Dev       Date:  1992-02       Impact factor: 11.361

2.  Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor.

Authors:  L R Bandara; N B La Thangue
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

3.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle.

Authors:  D W Goodrich; N P Wang; Y W Qian; E Y Lee; W H Lee
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

4.  Role of E2F transcription factor in E1A-mediated trans activation of cellular genes.

Authors:  S W Hiebert; M Blake; J Azizkhan; J R Nevins
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

6.  Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product.

Authors:  W G Kaelin; D C Pallas; J A DeCaprio; F J Kaye; D M Livingston
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

7.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product.

Authors:  P Whyte; K J Buchkovich; J M Horowitz; S H Friend; M Raybuck; R A Weinberg; E Harlow
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

8.  Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.

Authors:  L Cao; B Faha; M Dembski; L H Tsai; E Harlow; N Dyson
Journal:  Nature       Date:  1992-01-09       Impact factor: 49.962

9.  The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner.

Authors:  S Shirodkar; M Ewen; J A DeCaprio; J Morgan; D M Livingston; T Chittenden
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

10.  Identification of an E1A-inducible cellular factor that interacts with regulatory sequences within the adenovirus E4 promoter.

Authors:  P Raychaudhuri; R Rooney; J R Nevins
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

View more
  10 in total

1.  Transcription factor E2F binds DNA as a heterodimer.

Authors:  H E Huber; G Edwards; P J Goodhart; D R Patrick; P S Huang; M Ivey-Hoyle; S F Barnett; A Oliff; D C Heimbrook
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

2.  A binding site for transcription factor E2F is a target for trans activation of murine thymidine kinase by polyomavirus large T antigen and plays an important role in growth regulation of the gene.

Authors:  E Ogris; H Rotheneder; I Mudrak; A Pichler; E Wintersberger
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

Review 3.  Protein-protein interactions: methods for detection and analysis.

Authors:  E M Phizicky; S Fields
Journal:  Microbiol Rev       Date:  1995-03

4.  Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1.

Authors:  N Dyson; M Dembski; A Fattaey; C Ngwu; M Ewen; K Helin
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

5.  Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression.

Authors:  S W Hiebert
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

6.  Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.

Authors:  D Melamed; N Tiefenbrun; A Yarden; A Kimchi
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.

Authors:  Y W Kim; G A Otterson; R A Kratzke; A B Coxon; F J Kaye
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

8.  Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.

Authors:  M Arroyo; P Raychaudhuri
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

9.  Activation of a retinoblastoma-protein-dependent pathway by sphingosine.

Authors:  G S Dbaibo; R A Wolff; L M Obeid; Y A Hannun
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

10.  E2F and its developmental regulation in Xenopus laevis.

Authors:  A Philpott; S H Friend
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.